From: DE-CMR and MPS for assessment of myocardial viability: to what extent do the two techniques agree?
Age (Mean ± S.D) | 63.2 ± 11.1 |  |  |
Male (n, %) | 41 (78.8) | Â | Â |
Diagnosis (n, %) | |||
Ischaemic heart disease | 42 (80.8) | Â | Â |
Cardiomyopathy | 4 (7.69) | Â | Â |
Arrhythmia | 4 (7.69) | Â | Â |
Valvular | 2 (3.85) | Â | Â |
Co-morbidities/Risk factors (n, %) | |||
Diabetes | 7 (13.5) | Â | Â |
Hypertension | 29 (55.8) | Â | Â |
Hypercholesterolaemia | 18 (34.6) | Â | Â |
Smoker/ex-smoker | 18 (34.6) | Â | Â |
Previous intervention | 30 (57.7) | Â | Â |
PCI | 27 (51.9) | Â | Â |
CABG | 2 (3.85) | Â | Â |
Previous MI | 38 (73.1) | Â | Â |
Pulmonary disease | 12 (23.1) | Â | Â |
Known CAD | 43 (82.7) | Â | Â |
AF | 6 (11.5) | Â | Â |
LBBB | 4 (7.69) | Â | Â |
Outcomes (n, %) | |||
Alive | 51 (98.1) | Â | Â |
Revascularised after scans | 13 (25.0) | Â | Â |
Kappa statistics comparing imaging variables on DE-CMR and resting MPS | |||
Viable CMR segments | DE | Wall thinning | Wall motion |
Processed counts | 0.261 | 0.064 | 0.167 |
Thickening | 0.267 | 0.056 | 0.218 |
Motion | 0.195 | 0.065 | 0.167 |